OCT Vibrography for Biomechanical Properties of Tissues
Massachusetts General Hospital · with Massachusetts Eye and Ear Infirmary · NCT05759780
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 90
- US sites recruiting
- 1
- Study start
- August 19, 2023
- Record last updated
- October 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The overall goal of this study is to develop OCT Vibrography (aka OCT elastography) as a novel tool for measuring biomechanical properties of human tissues in vivo.
Being studied: Optical imaging of the tissues
Conditions: Cornea; Skin Diseases; Gingival Diseases
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Group 1:
Inclusion criteria
- Subjects with healthy eyes (age 18 - 75, N = 50)
Exclusion criteria
- Subjects with history of eye diseases, and previous eye surgeries.
- Subjects with diabetes, glaucoma family history
- Subjects allergic to anesthetic eyedrop, especially proparacaine
- Subjects with severe allergy
- Subjects who have difficulty biting
- Subjects who have recurrent corneal erosion
Group 2:
Inclusion criteria
- Subjects with healthy skin (age 18 - 75, N = 10)
Exclusion criteria
- Subjects with open cuts/sores on the skin, skin infection, or any contagious skin condition
Group 3:
Inclusion criteria
- Subjects with healthy gingiva (age 18 - 75, N = 10)
Exclusion criteria
- Subjects with open cuts/sores on the gingiva, gingiva infection, or any contagious gingiva condition
Group 4:
Inclusion criteria
- Mild or moderate keratoconus subjects (age 18 - 40, N = 20)
Exclusion criteria
- Subjects with K-max above 60 diopters (Pentacam imaging) are excluded
Recruiting US locations
Massachusetts General Hospital
Boston, MA 02114
Site contact: Jing Zhang, PhD · 6173730127 · jzhang110@mgh.harvard.edu
Study contacts (from the official record)
- Jing Zhang, PhD · 6173730127 · jzhang110@mgh.harvard.edu
- Seok-Hyun Yun, PhD · 6177688704 · syun@mgh.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+